Skip to content
Open access

Discovery of Non-Inhibitory Macrocyclic Ligands for Protein Tyrosine Phosphatase 1B Using a Function-Based, Iterative Screening Strategy

Jul 2026 · Journal of the American Chemical Society · Vol 148, pp. 32143 - 32154 · 0 citations · 43 references
Medicine

Abstract

Chemically induced proximity is a powerful modality for manipulating protein function. Most of the effort in this field has focused on targeted protein degradation but recruitment of other types of post-translational modification enzymes to a target protein is also of interest. To construct such reagents, one would ideally like to have ligands that engage the enzyme without inhibiting its activity. In this study, we describe a screening platform for the discovery of non-inhibitory macrocyclic ligands for a protein tyrosine phosphatase, using PTP1B as an exemplary model target. This workflow involves sequential screens of small libraries of bead-displayed macrocycles in which only one position of the macrocycle is varied in each round of screening while the others are held as invariant placeholders. The beads co-display a high KM substrate for the phosphatase, allowing ligand-dependent recruitment of the enzyme to the bead surface to be coupled to dephosphorylation of the co-displayed substrate. This is detected by staining with a labeled anti-phosphotyrosine antibody. Finally, we demonstrate that the same general approach can be applied to proteins lacking enzymatic activity by screening against biotin ligase-target protein fusions and employing a proximity labeling-like assay to register screening hits.

Read PDF

Similar papers

Open access Sep 2026

A Proximity-Driven Functional Screening Platform for the Discovery of Noninhibitory USP7 Ligand Enabling Targeted Protein Stabilization

A novel proximity-driven on-bead functional screening platform for the discovery of noninhibitory DUB ligands and generated DUBTACs, effectively stabilized CFTR protein levels in cells, demonstrating the potential of this platform for discovering DUB recruiters and facilitating the development of targeted protein stabi...

Kate E. Young, Janitha Kumarathunga, H. Kandambi et al. · 0 citations
Open access Aug 2026

Dissecting the binding landscape of four cKIT inhibitors through an integrated multifaceted approach.

This work highlights how distinct inhibitors exploit different conformational states of cKIT and demonstrates the value of integrating structural analyses, biophysical measurements, calculations and molecular simulations to define the mechanism of kinase inhibition.

Irene Cipollone, Carmen Gratteri, C. Talarico et al. · 0 citations
#protein folding Open access Sep 2026

A High-Throughput Assay to Identify Specific Nascent Chain Inhibitors

A high-throughput assay to identify small molecules that specifically inhibit a protein of interest in its nascent-chain form in its nascent-chain form is presented, providing a robust platform for larger-scale screening campaigns.

P. Fischer, Sebastian Hiller · 0 citations
Sep 2026

Exploiting Bridged Conformations for Precise Molecular Recognition in the Design of KRAS-Selective, Orally Available Macrocyclic Peptides

The results demonstrate that a conformational rigidification through a bridged scaffold, implemented while preserving membrane permeability, is a highly effective strategy for achieving isoform selectivity.

M. Kage, Hatsuo Kawada, Koji Takano et al. · 0 citations
Sep 2026

Design, synthesis, biological and computational evaluation of Thieno[3,2-d]pyrimidine-based inhibitors of JAK3 kinase.

JAK3 is a non-receptor tyrosine kinase that plays an important role in immune signaling pathways. It has long been indicated as a potential target for autoimmune diseases. In this work, a set of 28 novel JAK3 inhibitors were designed around a thieno[3,2-d]pyrimidine core, with aromatic moieties at the 2-position, and a...

Poowadon Fukasem, Kittitat Jaengwang, Duangkamol Gleeson et al. · 0 citations
Aug 2026

Discovery of Cbl-b Targeting Cyclic Peptide Ligands by Phage Display.

Cbl-b is a RING-type E3 ubiquitin ligase and intracellular immune checkpoint that negatively regulates immune-cell activation. However, ligand discovery for Cbl-b remains limited, largely because the RING-type E3 ubiquitin ligase is regulated by shallow and extended protein-protein interaction interfaces that are diffi...

Xiao-Qin Yang, Ming Wei, Wei-Kang Zhai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.